Literature DB >> 29575061

Association between site-specific bone mineral density and glucose homeostasis and anthropometric traits in healthy men and women.

Se-Min Kim1, Jinrui Cui1, Jane Rhyu1, Xiuqing Guo2, Yii-Der I Chen2, Willa A Hsueh3, Jerome I Rotter2, Mark O Goodarzi1.   

Abstract

OBJECTIVE: Patients with type 2 diabetes mellitus have an increased risk of fracture despite normal or increased bone mineral density (BMD). Studies on the relationship of glucose homeostasis with BMD phenotypes have been inconclusive because distinguishing the roles of insulin resistance and hyperglycaemia in bone remodelling is challenging. In this study, we sought to define the relationship of site-specific BMD with glucose homeostasis traits and anthropometric traits. DESIGN/PATIENTS/MEASUREMENTS: In a cross-sectional study, we examined 787 subjects from the Mexican-American Coronary Artery Disease (MACAD) cohort who had undergone euglycaemic-hyperinsulinaemic clamps, oral glucose tolerance testing and dual X-ray absorptiometry. Glucose homeostasis traits included insulinogenic index (IGI30), insulin sensitivity (M value), insulin clearance (MCRI), fasting insulin, fasting glucose and 2-hour glucose. Univariate and multivariate analyses were performed to assess the association of glucose homeostasis and anthropometric traits with site-specific BMD.
RESULTS: Two-hour glucose was negatively associated with arm BMD in women, which remained significant in multivariate analysis (β = -.15, P = .0015). Positive correlations between fasting insulin and BMD at weight-bearing sites, including pelvis (β = .22, P < .0001) and legs (β = .17, P = .001) in women and pelvis (β = .33, P < .0001) in men, lost significance after multivariate adjustment. Lean mass exhibited strong independent positive associations with BMD at multiple sites in both sexes.
CONCLUSION: Our findings suggest that (i) anabolic effects of insulin might work via mechanical loading from lean mass; (ii) a direct negative effect of increasing glucose might be more prominent at cortical-bone-rich sites in women; and (iii) lean mass is a strong positive predictor of bone mass.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  body composition; bone density; clinical study; diabetes complications; hyperglycaemia; insulin resistance; osteoporosis

Mesh:

Substances:

Year:  2018        PMID: 29575061      PMCID: PMC5980742          DOI: 10.1111/cen.13602

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  38 in total

1.  Osteoporosis assessment by whole body region vs. site-specific DXA.

Authors:  L Joseph Melton; Anne C Looker; John A Shepherd; Michael K O'Connor; Sara J Achenbach; B Lawrence Riggs; Sundeep Khosla
Journal:  Osteoporos Int       Date:  2005-04-06       Impact factor: 4.507

2.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Authors:  E Lalla; I B Lamster; M Feit; L Huang; A Spessot; W Qu; T Kislinger; Y Lu; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.

Authors:  N Ogata; D Chikazu; N Kubota; Y Terauchi; K Tobe; Y Azuma; T Ohta; T Kadowaki; K Nakamura; H Kawaguchi
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

5.  Association between lean mass, fat mass, and bone mineral density: a meta-analysis.

Authors:  Lan T Ho-Pham; Uyen D T Nguyen; Tuan V Nguyen
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

6.  Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism.

Authors:  M Inaba; M Terada; Y Nishizawa; A Shioi; E Ishimura; S Otani; H Morii
Journal:  Metabolism       Date:  1999-07       Impact factor: 8.694

7.  Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density.

Authors:  Senay Arikan; Alpaslan Tuzcu; Mithat Bahceci; Sehmuz Ozmen; Deniz Gokalp
Journal:  J Clin Densitom       Date:  2012-02-09       Impact factor: 2.617

8.  Association between insulin resistance and bone mass in men.

Authors:  Doosup Shin; Soyeun Kim; Kyae Hyung Kim; Kiheon Lee; Sang Min Park
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

9.  [Effect of progressive insulin resistance on the correlation of glucose metabolism and bone status].

Authors:  Barbara Buday; Tünde Horváth; Eniko Kulcsár; Csaba Salamon; Botond Literáti Nagy; Kitty Barta; Márta Vitai; Rita Józsa; Istvánné Vecsei; Katalin Bezzegh; József Kiss; Eva Péterfai; László Koltay; László Korányi
Journal:  Orv Hetil       Date:  2007-06-17       Impact factor: 0.540

10.  Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.

Authors:  Agostino Gaudio; Filippo Privitera; Katia Battaglia; Venerando Torrisi; Maria Helga Sidoti; Ivana Pulvirenti; Elena Canzonieri; Giovanni Tringali; Carmelo Erio Fiore
Journal:  J Clin Endocrinol Metab       Date:  2012-08-01       Impact factor: 5.958

View more
  2 in total

1.  A genetic correlation scan identifies blood proteins associated with bone mineral density.

Authors:  Jiawen Xu; Shaoyun Zhang; Haibo Si; Yi Zeng; Yuangang Wu; Yuan Liu; Mingyang Li; Limin Wu; Bin Shen
Journal:  BMC Musculoskelet Disord       Date:  2022-06-03       Impact factor: 2.562

2.  Relationship of Two-Hour Plasma Glucose and Abdominal Visceral Fat with Bone Mineral Density and Bone Mineral Content in Women with Different Glucose Metabolism Status.

Authors:  Xiaojiao Jia; Lanxiang Liu; Rui Wang; Xiaoli Liu; Binbin Liu; Ning Ma; Qiang Lu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-20       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.